logo

Gw Pharmaceuticals Plc (GWPH)



Trade GWPH now with
  Date
  Headline
7/16/2018 6:47:42 AM New Drugs Approved In June
4/12/2018 7:14:37 AM GW Pharmaceuticals And U.S. Subsidiary Greenwich Biosciences To Present Data On Epidiolex At AAN
2/27/2018 7:08:54 AM GW Pharmaceuticals Receives Orphan Drug Designation From EMA For Cannabidiol For Treatment Of Tuberous Sclerosis
12/29/2017 7:03:39 AM GW Pharma Submits MAA In Europe For Epidiolex In Treatment Of Lennox-Gastaut Syndrome And Dravet Syndrome
12/28/2017 7:04:09 AM GW Pharma Announces Acceptance Of NDA Filing For Epidiolex In Treatment Of Lennox-Gastaut Syndrome And Dravet Syndrome